Mitochondria signaling to the epigenome: A novel role for an old organelle.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and preclinical studies without new human data or systematic review methodology.
PubMed 33271282 · doi:10.1016/j.freeradbiomed.2020.11.016
What was done
This is a narrative review synthesizing literature on how mitochondrial function and metabolism influence the nuclear epigenetic landscape. The authors examine the biochemical mechanisms through which mitochondrial metabolites act as substrates and co-factors for chromatin-modifying enzymes, and the consequences of mitochondrial dysfunction on gene expression.
What was found
The abstract reports no numerical data or quantitative effect sizes. It describes qualitative biochemical links: tricarboxylic acid (TCA) cycle intermediates generated in the mitochondria—specifically acetyl-CoA and alpha-ketoglutarate—are required by enzymes that add or remove histone marks and regulate nuclear DNA methylation patterns, meaning mitochondrial dysfunction directly alters the epigenetic landscape.
Why it matters
This review highlights the role of mitochondria not just as energetic organelles but as upstream metabolic signaling hubs that directly shape nuclear gene expression via the epigenome.
Limits
This is a narrative review with no systematic search methodology, no quantitative meta-analysis, and no primary clinical or human empirical data reported in the abstract.
Cited by
- supports Mitochondrial metabolites such as acetyl-CoA, citrate, lactate, and alpha-ketoglutarate act as messengers to the nucleus that modify the epigenome and alter gene expression.